Triple-negative breast cancer (TNBC), characterized by the absence of ER, PR, and HER2, represents approximately 15~20% of all breast cancers [6]; however, its metastasis and mortality are significantly worse than those of other subtypes [7]. The gene discussed is ERBB2; the disease is breast cancer.